E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials-2025/7/21

国家药监局关于注销全自动医用PCR分析仪等2个医疗器械注册证书的公告（2025年第83号）-2025/9/4

Document: Agenda - Instrument for Pre-accession Assistance (IPA) training on assessing medicinal products in the EU: A practical introduction-2025/10/7

Document: Questions and answers on classification of a product as intended for a limited market according to Article 4(29) and/or eligibility for authorisation according to Article 23 (Applications for limited markets)-2025/11/14

Document: Draft user manual for the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) user interface (XEVMPDweb)-2025/12/10

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 8-11 December 2025-2026/1/23

Page: Quality of medicines: questions and answers - Part 1-2026/3/2

Document: EU implementation strategy of ICH E2D(R1) Guideline - Post-approval safety data: Definitions and standards for management and reporting of individual case safety reports-2026/3/27

Document: Applications for new human medicines under evaluation: May 2026-2026/5/11

Page: Cookies-2026/6/24